News FDA approvals expand reach of Roche's Zelboraf and Alecensa New US indications for Zelboraf and Alecensa
News EU regulators back J&J's Zytiga in early prostate cancer use New use could give J&J drug edge over Pfizer's rival
News Pfizer could fetch $15bn for consumer health business Pfizer is considering selling its consumer healthcare business in a deal that could be worth around $15 billion.
Partner Content Partner Content How to create an integrated social media and digital strateg... Social Media in Pharma
R&D SpringWorks spins out of Pfizer on rare disease mission A new biotech spun out of Pfizer is to develop four drugs for rare and serious diseases.
News FDA advisers split on new kidney cancer use for Pfizer's Sut... Committee could not decide if Sutent can be used after the removal of a cancerous kidney.
Patients Making direct-to-patient work, with Matt Wadyka Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
